News
Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025: Cambridge, Massachusetts Friday, August 1, 2025, 18 ...
Maxivision Super Speciality Eye Hospital launches 10 super speciality eye hospitals across Chennai: Our Bureau, Mumbai Friday, August 1, 2025, 17:40 Hrs [IST] Maxivision Super Spe ...
Cardiosense receives US FDA 510(k) clearance for its CardioTag device: Chicago Friday, August 1, 2025, 17:00 Hrs [IST] Cardiosense, a medical AI company transforming cardiovascula ...
Novo Nordisk, a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine ...
Conshohocken, Pa. Friday, August 1, 2025, 15:00 Hrs [IST] ...
Aclaris Therapeutics announces positive top-line results from phase 2a clinical trial of ATI-2138: Wayne, Pennsylvania Friday, August 1, 2025, 14:00 Hrs [IST] Aclaris Therapeutics ...
Egg Medical announces USPTO issues final rejection of all claims in Rampart IC's radiation shield patent following a reexamination challenge: St. Paul, Minn. Friday, August 1, 202 ...
Sun Pharmaceutical Industries reported a decline of 20 per cent in net profit at Rs. 2,278.63 crore during the first quarter of the current fiscal year, as compared to Rs. 2,835.62 crore during the ...
Illumina introduces next generation cancer research assay, TruSight Oncology 500: San Diego Friday, August 1, 2025, 12:00 Hrs [IST] Illumina Inc., a biotechnology company develops ...
Beta-HPV can directly cause skin cancer in immunocompromised people: Study: Maryland Friday, August 1, 2025, 11:00 Hrs [IST] Researchers at the National Institutes of Health (NIH) ...
Our Bureau, Bengaluru Friday, August 1, 2025, 10:45 Hrs [IST] ...
US FDA grants orphan drug designation to Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns to treat multiple myeloma: Paris Friday, August 1, 2025, 09:00 Hrs [IST] The US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results